Neuromyelitis optica in patients with increased interferon alpha concentrations - Institut Pasteur Access content directly
Journal Articles The Lancet Neurology Year : 2020

Neuromyelitis optica in patients with increased interferon alpha concentrations

Abstract

Recombinant interferon alpha is used to treat several immunological, oncological, and infectious diseases,1 and various serious side-effects have been associated with its therapeutic use. We want to bring attention to the development of neuromyelitis optica spectrum disorder (NMOSD) [...]

Domains

Immunology

Dates and versions

pasteur-02430155 , version 1 (07-01-2020)

Identifiers

Cite

Jac Williams, Sarah Mcglasson, Sarosh Irani, Darragh Duffy, Yanick Crow, et al.. Neuromyelitis optica in patients with increased interferon alpha concentrations. The Lancet Neurology, 2020, 19 (1), pp.31-33. ⟨10.1016/S1474-4422(19)30445-4⟩. ⟨pasteur-02430155⟩

Collections

INSERM PASTEUR
24 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More